Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform combines the latest advancements in computational chemistry, visualization of molecular interactions, and data integration to design orally available, superior medicines that overcome current limitations in biologic and peptide drugs. Structure is advancing a pipeline of small molecules (GLP1, amylin) for the treatment of obesity and other metabolic diseases.